Bugs in the system: bringing the human microbiome to bear in cancer immunotherapy.


Journal

Gut microbes
ISSN: 1949-0984
Titre abrégé: Gut Microbes
Pays: United States
ID NLM: 101495343

Informations de publication

Date de publication:
2019
Historique:
pubmed: 6 9 2018
medline: 8 8 2019
entrez: 6 9 2018
Statut: ppublish

Résumé

The influence of the composition of the human microbiome on the efficacy of cancer directed immunotherapies, such as antibodies directed against the programmed cell death 1 protein (PD-1) or its ligand (PD-L1), has garnered increasing attention as the role of immunotherapies in the care of cancer has grown. Dysbiosis (altered microbiota) has recently been reported to adversely affect the efficacy of cancer directed immunotherapies, and correction of this dysbiosis has the potential to improve the efficacy of these treatments. However, the exact mechanisms underlying this relationship remains unknown. Current methods for characterizing the microbiome likely capture only a small portion of the highly complex interaction between the microbiome and the immune system. Here we discuss the recent reports of the influence of dysbiosis on cancer immunotherapy, methods to more fully characterize the interaction between the microbiome and the immune system, and methods of modulating the immune system to improve the efficacy of cancer immunotherapy.

Identifiants

pubmed: 30183502
doi: 10.1080/19490976.2018.1511665
pmc: PMC6546317
doi:

Substances chimiques

Anti-Bacterial Agents 0
Antibodies, Monoclonal 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

109-112

Subventions

Organisme : NCI NIH HHS
ID : P30 CA086862
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES005605
Pays : United States

Références

Nature. 2012 Jun 13;486(7402):207-14
pubmed: 22699609
J Clin Invest. 2014 Oct;124(10):4212-8
pubmed: 25271726
Int J Cancer. 2018 Feb 15;142(4):769-778
pubmed: 29023689
Nat Med. 2014 Feb;20(2):159-66
pubmed: 24390308
Gastroenterology. 2007 Jun;132(7):2313-9
pubmed: 17570206
Cell Host Microbe. 2017 Feb 8;21(2):208-219
pubmed: 28182951
Microbiome. 2016 Jun 24;4(1):32
pubmed: 27341799
Nature. 2018 Jan 11;553(7687):208-211
pubmed: 29323293
J Clin Oncol. 2015 Jun 10;33(17):1974-82
pubmed: 25605845
Science. 2013 Aug 2;341(6145):569-73
pubmed: 23828891
Science. 2018 Jan 5;359(6371):97-103
pubmed: 29097493
JAMA Oncol. 2018 Mar 01;4(3):358-365
pubmed: 29327043
PLoS Biol. 2016 Aug 19;14(8):e1002533
pubmed: 27541692
Science. 2018 Jan 5;359(6371):91-97
pubmed: 29097494
Anticancer Res. 2017 Jun;37(6):3195-3200
pubmed: 28551664
Curr Allergy Asthma Rep. 2015 Jul;15(7):39
pubmed: 26143390

Auteurs

Christopher Strouse (C)

a Division of Hematology, Oncology and Blood & Marrow Transplantation, Department of Internal Medicine , Holden Comprehensive Cancer Center , Iowa City , IA , USA.

Ashutosh Mangalam (A)

b Department of Pathology , University of Iowa Carver College of Medicine , Iowa City , IA , USA.

Jun Zhang (J)

a Division of Hematology, Oncology and Blood & Marrow Transplantation, Department of Internal Medicine , Holden Comprehensive Cancer Center , Iowa City , IA , USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH